Glucose metabolism and insulin secretion in the carcinoid syndrome.
D000328:Adult; D005947:Glucose / Q000378:metabolism* / Q000494:pharmacology; D005951:Glucose Tolerance Test; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000652:urine; D007328:Insulin / Q000378:metabolism*; D007329:Insulin Antagonists; D000078790:Insulin Secretion; D008175:Lung Neoplasms / Q000188:drug therapy / Q000378:metabolism*; D008297:Male; D008303:Malignant Carcinoid Syndrome / Q000188:drug therapy / Q000378:metabolism*; D008784:Methysergide / Q000494:pharmacology; D008875:Middle Aged; D010179:Pancreas / Q000378:metabolism; D012701:Serotonin / Q000494:pharmacology; D012702:Serotonin Antagonists; D013311:Streptozocin / Q000627:therapeutic use
D007328:Insulin; D007329:Insulin Antagonists; D012702:Serotonin Antagonists; D012701:Serotonin; D006897:Hydroxyindoleacetic Acid; D013311:Streptozocin; D005947:Glucose; D008784:Methysergide